The National Oncologic PET Registry: Lessons Learned for Coverage With Evidence Development

Sean Tunis, Danielle Whicher

Research output: Contribution to journalArticle

Abstract

The National Oncologic PET Registry (NOPR) was one of the first attempts of the Centers for Medicare & Medicaid Services (CMS) at coverage with evidence development. Under this coverage policy, the agency will provide payment for a technology only if patients and providers agree to enroll in a prospective study or registry. The NOPR was designed to determine if the results of positron emission tomography scans influence physicians' intended plans of patient management while imposing minimal restrictions on the use of such scans in the clinical setting. The experience of policymakers, methodologists, physicians, and patients with the NOPR provides some useful insights into the utility and challenges of implementing, financing, and creating a robust methodology for coverage with evidence development in the future. Moving to a system of evidence-based medical technology diffusion will require all health care decision makers to become involved in evidence generation and reach an agreement about the type of evidence required to make informed medical decisions.

Original languageEnglish (US)
Pages (from-to)360-365
Number of pages6
JournalJournal of the American College of Radiology
Volume6
Issue number5
DOIs
StatePublished - 2009
Externally publishedYes

    Fingerprint

Keywords

  • comparative effectiveness
  • Coverage with evidence development
  • National Oncologic PET Registry
  • positron emission tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this